ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (9)
2021
2019
-
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 37, Núm. 28, pp. 2571-2580
2017
2015
-
Pazopanib in pretreated advanced neuroendocrine tumors: A phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
Annals of Oncology, Vol. 26, Núm. 9, pp. 1987-1993
2011
-
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS)
Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 545-551
2010
-
SEOM clinical guidelines for the treatment of advanced colorectal cancer
Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 729-734
2008
-
Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer
Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 52-57
2006
-
Polymorphisms in DNA repair genes modulate survival in cisplatin/ gemcitabine-treated non-small-cell lung cancer patients
Annals of Oncology, Vol. 17, Núm. 4, pp. 668-675
2001
-
Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial
Journal of the National Cancer Institute, Vol. 93, Núm. 1, pp. 31-38